Details of the Drug

General Information of Drug (ID: DMHTIBR)

Drug Name

TAK-951

Indication

Disease Entry	ICD 11	Status	REF
Nausea and vomiting	MD90	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04557189) A Randomized Double-Blind, Sponsor-Open, Double-Dummy, Proof of Concept Phase 2 Study to Evaluate the Efficacy and Safety of TAK-951 Versus Ondansetron in the Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Subjects. U.S.National Institutes of Health.